Home/Filings/4/0001140361-21-025590
4//SEC Filing

TYLE PRAVEEN 4

Accession 0001140361-21-025590

CIK 0001516551other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 2:23 PM ET

Size

5.3 KB

Accession

0001140361-21-025590

Insider Transaction Report

Form 4
Period: 2021-07-22
TYLE PRAVEEN
Director
Transactions
  • Award

    Director Option Grant (Right to Buy)

    2021-07-22+250,000250,000 total
    Exercise: $0.14Exp: 2031-07-22Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Each of the Options shall be exercisable for a price of $0.14 per Option Share for ten years from July 22, 2021 (the "Grant Date") and all Options will vest 10% on the Grant Date and 90% in equal semiannual installments over two years.

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1
  • filerCIK 0001296936

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 2:23 PM ET
Size
5.3 KB